ExcepGen - Crunchbase Company Profile & Funding

Q: Who invested in ExcepGen?

ExcepGen has 9 investors including Oxonian Ventures And Apollo Projects.

Q: When was the last funding round for ExcepGen?

ExcepGen closed its last funding round on obfuscated from a Seed round.

Q: How much funding has ExcepGen raised to date?

ExcepGen has raised obfuscated.

Overview

ExcepGen

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About ExcepGen

CB Rank

20790

RNA based vaccines with tolerability close to the standard of care by dampening an excessive innate immune response

Founded

obfuscation

Private

Seed

San Francisco, California, United States

1-10

www.excepgen.com/

Biopharma

Biotechnology

Health Care

Life Science

Funding Rounds

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Barbara Mertins: Chief Scientific Officer & Co-founder
Thomas Folliard: CEO and Co-founder

Details

Legal Name

ExcepGen Inc.

Operating Status

Active

Company Type

For Profit

Founders

Barbara Mertins, Thomas Folliard

About the Company

ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

RNAx Platform

An mRNA encoded protein platform that modulates cellular response to RNA and lipid nanoparticles by reducing excessive innate immune activation.

Self-amplifying mRNA Vaccines

Vaccines that use self-replicating mRNA to produce antigens, enhancing immune response with potentially lower doses.

Research & Development

ExcepGen is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed
obfuscated obfuscation	Seed Round - ExcepGen	5	obfuscated obfuscation	RA Capital Management	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Oxonian Ventures	—	Seed Round - ExcepGen	—
Oxonian Ventures	—	Seed Round - ExcepGen	—
Oxonian Ventures	—	Seed Round - ExcepGen	—
Oxonian Ventures	—	Seed Round - ExcepGen	—
Oxonian Ventures	—	Seed Round - ExcepGen	—